Unobio
1 known investors
Find your way into Unobio
Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
Investors · 1
Competitors · 3
by search overlap
AviadoBio Website9 shared keywordsAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
bio6 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
IQVIA5 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Companies competing with Unobio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Unobio do?
- Unobio is a biotech company running drug discovery programs that begin with patient data and validate candidates against patient biology at each stage, aiming to improve translation rates from preclinical work to clinical trials. Its approach targets the failure of programs that clear in vitro and animal models but fail in later-stage clinical phases.
- Who are Unobio's investors?
- Unobio's investors include Focal Ventures.